Division of Medigene AG
Latest From MediGene Inc.
Asia Deal Watch: Antibody-Drug Conjugates Reign With Alliances Involving Celltrion, Miracogen & WuXi Biologics
Celltrion and iProgen will co-develop ADC candidates, Miracogen and Synaffix sign a technology license after a successful research collaboration, and WuXi will provide clinical trial material to NBE Therapeutics.
Salix’ botanical product Fulyzaq tested the limits of the conventional small molecule chemistry approach to ensuring the identity of drug substance. After a regulatory briefing with CDER Director Woodcock, the botanicals and CMC review teams agreed on a bioassay to bridge the gap in their regulatory perspectives.
Luye Pharma is the latest Chinese domestic drug manufacturer aiming to launch prescription traditional Chinese medicines in the U.S.
- Therapeutic Areas
- NeuroVir Therapeutics Inc.
- North America
- Parent & Subsidiaries
- Medigene AG
- Senior Management
- Contact Info
Phone: (858) 586-2240
10650 Scripps Ranch Blvd.
San Diego, CA 92131
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.